P

Inventor

ANDERSON KENNETH C

US32 patents
⚠️ This page may combine multiple inventors who share the name “ANDERSON KENNETH C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DANA FARBER CANCER INST INC

14 patents
US9988343B2Jun 5, 2018

Inhibitors of histone deacetylase

DANA FARBER CANCER INST INC7 citations83
US9950047B2Apr 24, 2018

XBP1, CD138, and CS1 peptides, pharmaceutical compositions that include the peptides, and methods of using such peptides and compositions

DANA FARBER CANCER INST INC9 citations80
US11517591B2Dec 6, 2022

Immunogenic peptides specific to BCMA and TACI antigens

DANA FARBER CANCER INST INC1 citations59
US11083783B2Aug 10, 2021

XBP1, CD138, and CS1 peptides

DANA FARBER CANCER INST INC0 citations59
US12005073B2Jun 11, 2024

Methods for modulating regulatory T cells, regulatory b cells, and immune responses using modulators of the april-taci interaction

DANA FARBER CANCER INST INC0 citations56
US11465983B2Oct 11, 2022

USP7 inhibitors for treating multiple myeloma

DANA FARBER CANCER INST INC1 citations53
US11702402B2Jul 18, 2023

Small molecules that block proteasome-associated ubiquitin receptor RPN13 function and uses thereof

DANA FARBER CANCER INST INC0 citations51
US11802132B2Oct 31, 2023

Small molecules for inducing selective protein degradation and uses thereof

DANA FARBER CANCER INST INC0 citations50
US11447467B2Sep 20, 2022

Compounds for the degradation of STK4 and treatment of hematologic malignancies

DANA FARBER CANCER INST INC0 citations49
US8026230B2Sep 27, 2011

Methods and compositions for treating cancer using proteasome inhibitors

DANA FARBER CANCER INST INC0 citations49
US12448429B2Oct 21, 2025

T cell receptors specific to b-cell maturation antigen for treatment of cancer

DANA FARBER CANCER INST INC0 citations48
US10302644B2May 28, 2019

Compositions and methods for treating multiple myeloma

DANA FARBER CANCER INST INC0 citations47
US12109266B2Oct 8, 2024

Modulating gabarap to modulate immunogenic cell death

DANA FARBER CANCER INST INC0 citations41
US9969679B2May 15, 2018

Anti-proliferative compounds and uses thereof

DANA FARBER CANCER INST INC0 citations36

ANDERSON KENNETH C

5 patents

ACETYLON PHARMACEUTICALS INC

3 patents

(unassigned)

2 patents

DEPINHO RONALD A

2 patents

HARVARD COLLEGE

2 patents

MASSACHUSETTS GEN HOSPITAL

1 patent

MUNSHI NIKHIL C

1 patent

ADAMS JULIAN

1 patent

CELGENE INT II SARL

1 patent